ClinConnect ClinConnect Logo
Search / Trial NCT03253835

Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage

Launched by MEDICAL UNIVERSITY OF GRAZ · Aug 17, 2017

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients age 20-80 years,
  • patients with and without ischemic or non-ischemic myocardial injuries scheduled for routine cardiac magnetic resonance imaging,
  • ability to hold the breath,
  • ability to give informed consent
  • Exclusion Criteria:
  • patients with metal devices or other magnetic material in or on the subjects body which will be hazardous for magnetic resonance investigation (e.g. heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile implants, colored contact lenses, patch to deliver medications through the skin, any metal implants as rods, joints, plates, pins, screws, nails or clips, embolization coil, or any metal fragments or shrapnel in the body),
  • patients with tendency toward claustrophobia,
  • hemodynamically unstable patients,
  • patients with (major) arrhythmia
  • pregnancy,
  • impaired kidney function indicated by creatin clearance lower than 60 ml/min (creatin clearance will be calculated according to Cockroft-Gault formula)

About Medical University Of Graz

The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.

Locations

Graz, Styria, Austria

Patients applied

0 patients applied

Trial Officials

Michael Fuchsjäger, Univ.-Prof.

Study Chair

Medical Universtiy of Graz

Ursula Reiter, PD DI Dr.

Principal Investigator

Medical Universtiy of Graz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials